The WISH lab was established in May 2014. A collaborative venture between University Hospital Southampton NHS Foundation Trust and the University of Southampton, it was built to meet the needs of industry partners, the growing need for research-dedicated, regulatory standard analytical capabilities and the emerging stratified medicine research agenda.
We offer development of novel assays and procedures requiring a high level of quality assurance and validation, including Phase I trial analytics. We work closely with the NIHR Southampton Clinical Research Facility. One of our first external partnerships was a commercial venture for a study of a vaccine for chronic obstructive pulmonary disease (COPD).
In December 2014, the WISH lab became the hub for the Wessex NHS Genomic Medicine Centre, one of 11 centres established within the UK. WISH also hosts the establishment Genomics England 100,000 genomes project, and is driving integration of Next Generation Sequencing capabilities into NHS hospital Trusts in the genome pilot program, working closely with specialist scientists from the Salisbury regional genetics centre. The Wessex NHS Genomic Medicine Centre serves 3.5 million people from Dorset, Wiltshire, Hampshire, Isle of Wight and areas within surrounding counties.
We are supported by investment from Cancer Research UK, the National Institute for Health Research, University Hospital Southampton NHS Foundation Trust, the University of Southampton, as well as our commercial partners.